MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

The post MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024 appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.